RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED IN THE U.S. 03/09/2020 Recordati Rare Diseases Statement Regarding COVID-19 03/06/2020 Recordati Rare Diseases, Inc. Announces Transfer of U.S. Marketing Rights to SIGNIFOR® (pasireotide) Injection and SIGNIFOR LAR® (pasireotide) for Injectable Suspension 02/20/2020 Pagination First page « First Previous page ‹ Previous … Page 9 Current page 10 Page 11 Page 12 … Next page Next › Last page Last »
Recordati Rare Diseases, Inc. Announces Transfer of U.S. Marketing Rights to SIGNIFOR® (pasireotide) Injection and SIGNIFOR LAR® (pasireotide) for Injectable Suspension 02/20/2020
